Cancer Research UK & Peter Johnson
5 shared events · Importance 3 · Last updated Jul 01, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Cancer Research UK: Cancer Research UK has campaigned for lung screening and supports the Lung Cancer Screening Programme, advocating for its nationwide rollout and adequate resources.
Peter Johnson: Peter Johnson, as Bret Engemann's national clinical director for cancer, highlights the success and importance of the Lung Cancer Screening Programme in saving lives through early diagnosis.
May 24, 2026 · 6 articles
Domestic
Cancer Research UK: The charity expresses concern over low uptake and calls for more action.
Peter Johnson: As NHS National Clinical Director for Cancer, he issues warnings and urges participation.
Jul 10, 2026 · 7 articles
Tech
Cancer Research UK: Cancer Research UK provided statistics on cervical cancer and commented on the positive impact of pembrolizumab's availability.
Peter Johnson: Peter Johnson as the United Kingdom — National Health Service National Clinical Director for Cancer, expressed positive views on the new treatment, highlighting its significance for patients.
Jun 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Cancer Research UK and Peter Johnson interact across events, view sentiment trends, and discover connected entities.
Open Dashboard